Flavonoids suppress androgen-independent human prostate tumor proliferation

被引:133
|
作者
Knowles, LM
Zigrossi, DA
Tauber, RA
Hightower, C
Milner, JA
机构
[1] Penn State Univ, Grad Program Nutr, University Pk, PA 16802 USA
[2] Penn State Univ, Dept Nutr, University Pk, PA 16802 USA
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2000年 / 38卷 / 01期
关键词
D O I
10.1207/S15327914NC381_16
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present studies compared the effects of selected bioflavonoids on the proliferation of androgen-independent human prostatic tumor cells (PC-3). Complete growth retardation was observed in PC-3 cells treated with 100 muM quercetin, kaempferol, and luteolin, while isomolar genistein, apigenin, and myricetin suppressed PC-3 proliferation by 73% 70%, and 59% respectively (p < 005). Naringenin and rutin were not as effective and inhibited growth by < 25%. Exposure to increasing concentrations of quercetin and kaempferol led to a dose-dependent decrease in proliferation. Refeeding kaempferol-treated cells (50 muM) complete medium without the flavonoid resulted in a return toward control growth rates. Similar growth recovery was not observed in quercetin-treated cells. The antiproliferative response of PC-3 cells to quercetin and kaempferol was additive when supplemented to the medium at 25 muM. A block in G(2)-to-M phase progression was observed after the addition of 25 muM kaempferol. When quercetin reached 100 muM, an increase in the proportion of cells in the S phase became apparent within 24 hours. Apoptosis was not evident, even when concentrations of quercetin or kaempferol were raised to 100 muM. The present studies suggest that alterations in cell cycle progression contribute significantly to the antiproliferative effects of quercetin and kaempferol in PC-3 cells.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 50 条
  • [31] New features in the treatment of androgen-independent prostate cancer
    Closset, J
    Ammar, H
    Nguyen, VH
    Cornet, A
    Reiter, E
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (05) : 513 - 522
  • [32] Stem Cell Genes in Androgen-independent Prostate Cancer
    Matthew Bui
    Robert E. Reiter
    Cancer and Metastasis Reviews, 1998, 17 : 391 - 399
  • [33] Low PSA metastatic androgen-independent prostate cancer
    Sella, A
    Konichezky, M
    Flex, D
    Sulkes, A
    Baniel, J
    EUROPEAN UROLOGY, 2000, 38 (03) : 250 - 254
  • [34] Development of the VCaP androgen-independent model of prostate cancer
    Loberg, RD
    St John, LN
    Day, LL
    Neeley, CK
    Pienta, KJ
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (02) : 161 - 168
  • [35] Future directions in the treatment of androgen-independent prostate cancer
    Petrylak, DP
    UROLOGY, 2005, 65 (6A) : 8 - 12
  • [36] Proteomic Signatures of Angiogenesis in Androgen-Independent Prostate Cancer
    Karagiannis, George S.
    Saraon, Punit
    Jarvi, Keith A.
    Diamandis, Eleftherios P.
    PROSTATE, 2014, 74 (03): : 260 - 272
  • [37] Signal Transduction Targets in Androgen-independent Prostate Cancer
    Jian Zhou
    Jessica Scholes
    Jer-Tsong Hsieh
    Cancer and Metastasis Reviews, 2001, 20 : 351 - 362
  • [38] Alternatives to death: Understanding androgen-independent prostate cancer
    Joel B. Nelson
    Nature Medicine, 1998, 4 : 1011 - 1012
  • [39] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Beer, TM
    Garzotto, M
    Henner, WD
    Eilers, KM
    Wersinger, EM
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 968 - 970
  • [40] Alternatives to death: Understanding androgen-independent prostate cancer
    Nelson, JB
    NATURE MEDICINE, 1998, 4 (09) : 1011 - 1012